review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/0168-1702(95)00048-U |
P698 | PubMed publication ID | 8546007 |
P2093 | author name string | Mateu MG | |
P433 | issue | 1 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 1-24 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Virus Research | Q15749215 |
P1476 | title | Antibody recognition of picornaviruses and escape from neutralization: a structural view | |
P478 | volume | 38 |
Q28742691 | A Brief Review on Diagnosis of Foot-and-Mouth Disease of Livestock: Conventional to Molecular Tools |
Q36870279 | A cyclic disulfide peptide reproduces in solution the main structural features of a native antigenic site of foot-and-mouth disease virus |
Q74615107 | A genotypic characterization of enteroviral antigenic variants isolated in eastern Canada |
Q39878888 | A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants |
Q45753381 | A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. |
Q41150504 | A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors |
Q40197802 | A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells |
Q40433238 | A segmented form of foot-and-mouth disease virus interferes with standard virus: a link between interference and competitive fitness. |
Q39577442 | A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation |
Q39606030 | A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. |
Q54228834 | A traditional evolutionary history of foot-and-mouth disease viruses in Southeast Asia challenged by analyses of non-structural protein coding sequences. |
Q34743841 | Analysis of SAT type foot-and-mouth disease virus capsid proteins and the identification of putative amino acid residues affecting virus stability |
Q40368026 | Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle |
Q45025178 | Analysis of the genetic and the corresponding antigenic variability of the VP1 3' end of ECHO virus type 11 and ECHO virus type 30. |
Q40397305 | Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India |
Q45742173 | Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran |
Q36874351 | Basic rationale, current methods and future directions for molecular typing of human enterovirus |
Q33744131 | Biochemical and structural studies with neutralizing antibodies raised against foot-and-mouth disease virus. |
Q39858755 | Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing. |
Q39589175 | Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage |
Q91576100 | Characterization and epidemiological survey of porcine sapelovirus in China |
Q34016372 | Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection |
Q44413461 | Characterization of the structural-protein-coding region of SAT 2 type foot-and-mouth disease virus |
Q44195968 | Characterizing sequence variation in the VP1 capsid proteins of foot and mouth disease virus (serotype 0) with respect to virion structure |
Q30157695 | Classification of duck hepatitis virus into three genotypes based on molecular evolutionary analysis |
Q44511132 | Complete alanine scanning of intersubunit interfaces in a foot-and-mouth disease virus capsid reveals critical contributions of many side chains to particle stability and viral function. |
Q37832197 | Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong |
Q84841816 | CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle |
Q50104255 | Detection and genetic characterization of bovine kobuvirus from calves in Egypt. |
Q37715371 | EV71: an emerging infectious disease vaccine target in the Far East? |
Q38843668 | Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O/ME-SA/Ind-2001 lineage collected in North Africa |
Q27469870 | Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors |
Q40015576 | Efficient neutralization of foot-and-mouth disease virus by monovalent antibody binding |
Q64066280 | Engineering Responses to Amino Acid Substitutions in the VP0- and VP3-Coding Regions of PanAsia-1 Strains of Foot-and-Mouth Disease Virus Serotype O |
Q39933463 | Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines |
Q40228705 | Enhanced immunogenicity to food-and-mouth disease virus in mice vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1). |
Q39763867 | Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. |
Q39662972 | Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield |
Q45734672 | Epidemiological implications of the molecular characterization of foot-and-mouth disease virus isolated between 1996 and 2000 in Bangladesh |
Q40589296 | Epitopes recognized by CBV4 responding T cells: effect of type 1 diabetes and associated HLA-DR-DQ haplotypes |
Q39733475 | Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals |
Q39699119 | Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo |
Q59269904 | Evolution and molecular epidemiology of foot-and-mouth disease virus in China |
Q35627059 | Evolution of cell recognition by viruses: a source of biological novelty with medical implications |
Q35044856 | Evolution of foot-and-mouth disease virus |
Q34806015 | Evolution of type 2 vaccine derived poliovirus lineages. Evidence for codon-specific positive selection at three distinct locations on capsid wall |
Q36240271 | Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. |
Q33788579 | Expression, purification and characterization of enterovirus-71 virus-like particles |
Q40327501 | First isolation and genetic characteristics of porcine sapeloviruses in Hunan, China |
Q34547126 | Foot-and-mouth disease |
Q42724166 | Foot-and-mouth disease in Europe. FMD is economically the most important disease of farm animals. Its re-emergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade |
Q34940508 | Foot-and-mouth disease virus |
Q40468573 | Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice. |
Q34935334 | Foot-and-mouth disease virus: biology and prospects for disease control |
Q40923408 | Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives. Implications for the evolution of viral quasispecies during a persistent infection |
Q39198958 | Growth kinetics and immune response of chimeric foot-and-mouth disease virus serotype 'O' produced through replication competent mini genome of serotype Asia 1, 63/72, in BHK cell lines |
Q40128599 | Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host |
Q30389296 | Heterogeneity and genetic variations of serotypes O and Asia 1 foot-and-mouth disease viruses isolated in Vietnam |
Q34472287 | High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host |
Q38768816 | Human Rhinovirus Diversity and Evolution: How Strange the Change from Major to Minor |
Q39602247 | Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. |
Q35544351 | Identification of a common epitope between enterovirus 71 and human MED25 proteins which may explain virus-associated neurological disease |
Q33727493 | Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8 |
Q45647095 | Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. |
Q40609806 | In vitro disassembly of a parvovirus capsid and effect on capsid stability of heterologous peptide insertions in surface loops |
Q33944915 | In-vitro and in-vivo phenotype of type Asia 1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. |
Q44551896 | Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus |
Q39021114 | Isolation and identification of enteroviruses from sewage and sewage-contaminated water in Lagos, Nigeria |
Q35881226 | Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease |
Q54352652 | Mapping B-cell epitopes in equine rhinitis B viruses and identification of a neutralising site in the VP1 C-terminus. |
Q33243910 | Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment |
Q35044850 | Molecular basis of pathogenesis of FMDV. |
Q44278447 | Molecular characterization of foot-and-mouth disease virus in Hong Kong during 2001-2002. |
Q37320099 | Molecular classification of enteroviruses not identified by neutralization tests |
Q42255561 | Molecular epidemiology of Korean porcine sapeloviruses. |
Q42228891 | Molecular evolution of VP3, VP1, 3C(pro) and 3D(pol) coding regions in coxsackievirus group A type 24 variant isolates from acute hemorrhagic conjunctivitis in 2011 in Okinawa, Japan. |
Q41128941 | Molecular evolution of aphthoviruses |
Q24517799 | Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification |
Q38021264 | Molecular recognition in the human immunodeficiency virus capsid and antiviral design |
Q48338880 | Molecular typing of echovirus serotype 4 isolates |
Q33992691 | Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis |
Q39579299 | Multiple virulence determinants of foot-and-mouth disease virus in cell culture |
Q27477453 | Mutagenesis versus Inhibition in the Efficiency of Extinction of Foot-and-Mouth Disease Virus |
Q41036387 | Mutational analysis of discontinuous epitopes of foot-and-mouth disease virus using an unprocessed capsid protomer precursor |
Q41583623 | Mutations for decreasing the immunogenicity and maintaining the function of core streptavidin |
Q41989022 | Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus. |
Q42053061 | Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B |
Q48038705 | Phenotypic and genotypic variation of feline calicivirus during persistent infection of cats. |
Q82540877 | Phylogenetic analysis of Indian serotype Asia1 foot-and-mouth-disease virus isolates revealed emergence and reemergence of different genetic lineages |
Q35834047 | Phylogenetic and molecular characterization of coxsackievirus A24 variant isolates from a 2010 acute hemorrhagic conjunctivitis outbreak in Guangdong, China. |
Q37254352 | Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission |
Q42246823 | Phylogeny and genetic diversity of foot and mouth disease virus serotype Asia1 in India during 1964-2012. |
Q44178765 | Probing degeneracy in antigen-antibody recognition at the immunodominant site of foot-and-mouth disease virus. |
Q40090477 | Productive entry of type C foot-and-mouth disease virus into susceptible cultured cells requires clathrin and is dependent on the presence of plasma membrane cholesterol |
Q41676952 | Re-emergence of circulatory foot-and-mouth disease virus serotypes Asia1 in Bangladesh and VP1 protein heterogeneity with vaccine strain IND 63/72. |
Q39997584 | Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. |
Q48120112 | Revealing molecular targets for enterovirus type 71 detection by profile hidden Markov models |
Q36851964 | Role of interfacial amino acid residues in assembly, stability, and conformation of a spherical virus capsid |
Q39079735 | Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus |
Q44141659 | Sequence and phylogenetic analysis of the L and VP1 genes of foot-and-mouth disease virus serotype Asia1. |
Q39604868 | Sequence conservation and antigenic variation of the structural proteins of equine rhinitis A virus |
Q42227938 | Sequence variability in the structural protein-encoding region of foot-and-mouth disease virus serotype A and O of Ethiopian isolates |
Q33769118 | Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus |
Q35969054 | Serological Survey of Foot-and-Mouth Disease Virus in Buffaloes (Syncerus caffer) in Zambia |
Q42052011 | Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens |
Q32066676 | Structure of a neutralizing antibody bound monovalently to human rhinovirus 2 |
Q40642867 | Subcellular localisation of Theiler's murine encephalomyelitis virus (TMEV) capsid subunit VP1 vis-á-vis host protein Hsp90. |
Q59201855 | Successful mimicry of a complex viral antigen by multiple peptide insertions in a carrier protein |
Q41197317 | Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition |
Q39822124 | Systematic study of the genetic response of a variable virus to the introduction of deleterious mutations in a functional capsid region |
Q45324603 | The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate |
Q33182380 | The generation and persistence of genetic variation in foot-and-mouth disease virus |
Q34043450 | The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. |
Q28080796 | Therapeutic and prevention strategies against human enterovirus 71 infection |
Q44449795 | Thermodynamic dissection of a low affinity protein-protein interface involved in human immunodeficiency virus assembly |
Q39880172 | Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. |
Q43846434 | Type-independent detection of foot-and-mouth disease virus by monoclonal antibodies that bind to amino-terminal residues of capsid protein VP2. |
Q33971813 | Type-specific detection of echovirus 30 isolates using degenerate reverse transcriptase PCR primers |
Q41906944 | Typing of human enterovirus by partial sequencing of VP2. |
Q33960048 | Typing of human enteroviruses by partial sequencing of VP1. |
Q37173132 | Unravelling selection shifts among foot-and-mouth disease virus (FMDV) serotypes. |
Q39395273 | Update on molecular characterization of coxsackievirus B5 strains |
Q34123873 | Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon |
Q27013917 | Viral quasispecies evolution |
Q37798083 | Virus engineering: functionalization and stabilization |
Search more.